Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population

Figures & data

Table 1 Clinical and structural characteristics of patients with abdominal aortic aneurysm (AAA) and controls

	Group 1	Group 2
Number of patients	98	82
Male/Females	76/22	50/32
Age	74 ± 8	74 ± 8
Infrarenal AAA	81	2
Suprarenal AAA	17
Mean transverse diameter (infra/super-renal)	5.4 (5.9/4.8)	4.5 ± 0.3
% of endo luminal thrombus	45%

Figure 1 Prevalence of carotid disease (CAROTID), peripheral arterial disease (PAD), and coronary artery disease (CAD) in the two groups.

Figure 2 HDL cholesterol difference in AAA with and without thrombus and in controls.

Abbreviations: AAA, abdominal aortic aneurysm; HDL, high-density lipoprotein.

Table 2 Association between classical risk factors in abdominal aortic aneurysm (AAA) subjects and in controls with two or more risk factors

Risk factor	Control group	AAA group	P
Peripheral vascular disease	15 (19%)	19 (20%)	n.s.
CAD	17 (23%)	25 (26%)	n.s.
Carotid atherosclerosis	18 (25%)	9 (9%)	<0.004
BMI	28 ± 3.6	29 ± 3.8	n.s.
Total cholesterol	197 ± 25	199 ± 20	n.s.
Cholesterol >200 mg/dl	35%	33%	n.s.
LDL cholesterol	140 ± 18	142 ± 16	n.s.
HDL cholesterol	47.5 ± 6.5	52.1 ± 7.8	<0.003
Tryglicerides	144 ± 56	138 ± 45	n.s.
Diabetes	122 ± 20	119 ± 15	n.s.
hsCRP	2.8 ± 1.3	1.3 ± 0.7	<0.001
Systolic BP	143 ± 14	150 ± 15	<0.001
Diastolic BP	85 ± 7	88 ± 6	<0.05
BP >140/90	42%	71%	<0.0006
Smoking	31 (40%)	59 (66%)	<0.002
Fibrinogen	362 ± 92	388 ± 154	n.s.

Abbreviations: CAD, Coronary Disease; BMI, Body Mass Index; hsCRP, high sensivity C-Reactive Protein; BP, Blood Pressure.

Figure 3 Different levels of fibrinogen in AAA with and without thrombus and in controls.

Abbreviation: AAA, abdominal aortic aneurysm.